Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LA Jolla Pharma (NQ: LJPC )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 4.000 (1)
Ask (Size) 6.250 (9)
Prev. Close 6.220
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 24,936,883
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Innoviva Completes Acquisition of La Jolla Pharmaceutical
From Innoviva, Inc.
Via Business Wire
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire

Performance

More News

Read More
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC
From Kahn Swick & Foti, LLC
Via Business Wire
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
Via Benzinga
Dow Dips Around 90 Points; La Jolla Pharmaceutical Shares Surge
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Nasdaq Tumbles 2%; Pliant Therapeutics Shares Spike Higher
Via Benzinga
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
5 Top Short Squeeze Stocks to Watch This Week
Via InvestorPlace
La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News
Via InvestorPlace
Why U.S. Stocks Are Trading Lower; AZZ Earnings And More
Via Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
Via Benzinga
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal
Via Benzinga
Innoviva to Acquire La Jolla Pharmaceutical Company
From La Jolla Pharmaceutical Company
Via Business Wire
Recap: La Jolla Pharmaceutical Q1 Earnings
Via Benzinga
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress
From La Jolla Pharmaceutical Company
Via Business Wire
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
La Jolla Pharmaceutical Company Announces Share Repurchase Plan
From La Jolla Pharmaceutical Company
Via Business Wire
50 Biggest Movers From Yesterday
Via Benzinga
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress
From La Jolla Pharmaceutical Company
Via Business Wire
Tony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical Company
From La Jolla Pharmaceutical Company
Via Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress
From La Jolla Pharmaceutical Company
Via Business Wire
99 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.